AU2014367781B2 - Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain - Google Patents
Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain Download PDFInfo
- Publication number
- AU2014367781B2 AU2014367781B2 AU2014367781A AU2014367781A AU2014367781B2 AU 2014367781 B2 AU2014367781 B2 AU 2014367781B2 AU 2014367781 A AU2014367781 A AU 2014367781A AU 2014367781 A AU2014367781 A AU 2014367781A AU 2014367781 B2 AU2014367781 B2 AU 2014367781B2
- Authority
- AU
- Australia
- Prior art keywords
- pain
- dihydro
- inden
- sulfamide
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C)(C)OC(*(C(Cc1c2c(Cl)cc(F)c1)(C2N1)F)S1(=O)=O)=O Chemical compound CC(C)(C)OC(*(C(Cc1c2c(Cl)cc(F)c1)(C2N1)F)S1(=O)=O)=O 0.000 description 2
- NVCAZAGJVMRTKA-UHFFFAOYSA-N Cc1cc(F)cc(CC2(F)F)c1C2O Chemical compound Cc1cc(F)cc(CC2(F)F)c1C2O NVCAZAGJVMRTKA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013262743 | 2013-12-19 | ||
| JP2013-262743 | 2013-12-19 | ||
| PCT/JP2014/083374 WO2015093515A1 (ja) | 2013-12-19 | 2014-12-17 | １－インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014367781A1 AU2014367781A1 (en) | 2016-06-23 |
| AU2014367781B2 true AU2014367781B2 (en) | 2019-07-04 |
Family
ID=53402860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014367781A Active AU2014367781B2 (en) | 2013-12-19 | 2014-12-17 | Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9610262B2 (enExample) |
| EP (1) | EP3085369B1 (enExample) |
| JP (1) | JP6518595B2 (enExample) |
| KR (1) | KR102250214B1 (enExample) |
| CN (1) | CN105792821B (enExample) |
| AU (1) | AU2014367781B2 (enExample) |
| BR (1) | BR112016012833B1 (enExample) |
| CA (1) | CA2932529C (enExample) |
| ES (1) | ES2673876T3 (enExample) |
| IL (1) | IL246036B (enExample) |
| MX (1) | MX370898B (enExample) |
| RU (1) | RU2678571C1 (enExample) |
| SG (1) | SG11201604484UA (enExample) |
| WO (1) | WO2015093515A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11660275B2 (en) * | 2018-03-20 | 2023-05-30 | Eisai R&D Management Co., Ltd. | Epilepsy treatment agent |
| KR20250005086A (ko) | 2022-04-27 | 2025-01-09 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 파킨슨병의 치료를 위한 약학적 조성물 |
| KR102803991B1 (ko) | 2022-11-11 | 2025-05-13 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102815520B1 (ko) | 2022-11-11 | 2025-06-04 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102815521B1 (ko) | 2022-11-11 | 2025-06-04 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR20250063588A (ko) | 2023-11-01 | 2025-05-08 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
| KR20250063587A (ko) | 2023-11-01 | 2025-05-08 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
| KR20250063589A (ko) | 2023-11-01 | 2025-05-08 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013191144A1 (ja) * | 2012-06-21 | 2013-12-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規インダンスルファミド誘導体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8716231B2 (en) * | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US20070191452A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain |
| CL2007002994A1 (es) | 2006-10-19 | 2008-02-08 | Wyeth Corp | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. |
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| EP2417101B1 (en) | 2009-04-09 | 2013-10-23 | Merck Sharp & Dohme B.V. | Indane derivatives |
| TW201217312A (en) * | 2010-09-22 | 2012-05-01 | Gruenenthal Gmbh | Substituted benzamide compounds |
| RU2508295C2 (ru) * | 2012-03-22 | 2014-02-27 | Общество с ограниченной ответственностью "Биофармокс" | Синтетические пептиды с ненаркотическим типом анальгетического действия |
-
2014
- 2014-12-17 KR KR1020167014850A patent/KR102250214B1/ko active Active
- 2014-12-17 MX MX2016007370A patent/MX370898B/es active IP Right Grant
- 2014-12-17 WO PCT/JP2014/083374 patent/WO2015093515A1/ja not_active Ceased
- 2014-12-17 BR BR112016012833-8A patent/BR112016012833B1/pt active IP Right Grant
- 2014-12-17 CN CN201480066081.3A patent/CN105792821B/zh active Active
- 2014-12-17 AU AU2014367781A patent/AU2014367781B2/en active Active
- 2014-12-17 JP JP2015553575A patent/JP6518595B2/ja active Active
- 2014-12-17 CA CA2932529A patent/CA2932529C/en active Active
- 2014-12-17 ES ES14871860.4T patent/ES2673876T3/es active Active
- 2014-12-17 SG SG11201604484UA patent/SG11201604484UA/en unknown
- 2014-12-17 US US15/102,046 patent/US9610262B2/en active Active
- 2014-12-17 EP EP14871860.4A patent/EP3085369B1/en active Active
- 2014-12-17 RU RU2016122189A patent/RU2678571C1/ru active
-
2016
- 2016-06-05 IL IL246036A patent/IL246036B/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013191144A1 (ja) * | 2012-06-21 | 2013-12-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規インダンスルファミド誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2673876T3 (es) | 2018-06-26 |
| CN105792821B (zh) | 2018-05-04 |
| CA2932529C (en) | 2022-03-22 |
| CN105792821A (zh) | 2016-07-20 |
| EP3085369B1 (en) | 2018-04-04 |
| EP3085369A1 (en) | 2016-10-26 |
| IL246036B (en) | 2018-11-29 |
| CA2932529A1 (en) | 2015-06-25 |
| US20160303058A1 (en) | 2016-10-20 |
| BR112016012833B1 (pt) | 2022-11-16 |
| WO2015093515A1 (ja) | 2015-06-25 |
| SG11201604484UA (en) | 2016-07-28 |
| KR102250214B1 (ko) | 2021-05-07 |
| JP6518595B2 (ja) | 2019-05-22 |
| JPWO2015093515A1 (ja) | 2017-03-23 |
| AU2014367781A1 (en) | 2016-06-23 |
| KR20160106053A (ko) | 2016-09-09 |
| RU2678571C1 (ru) | 2019-01-30 |
| EP3085369A4 (en) | 2017-05-10 |
| US9610262B2 (en) | 2017-04-04 |
| IL246036A0 (en) | 2016-07-31 |
| MX370898B (es) | 2020-01-09 |
| BR112016012833A2 (enExample) | 2017-08-08 |
| MX2016007370A (es) | 2016-10-03 |
| RU2016122189A (ru) | 2018-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014367781B2 (en) | Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain | |
| EP1602369B1 (en) | Bupropion Metabolites for treating anxiety | |
| AU2021215274B2 (en) | Targeted drug rescue with novel compositions, combinations, and methods thereof | |
| JP6528779B2 (ja) | びまん性大細胞型ｂ細胞リンパ腫の予防および／または治療剤 | |
| CA2738768A1 (en) | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors | |
| KR20030051879A (ko) | 세로토닌성 제제 | |
| WO2022042657A1 (en) | Compounds and methods of use | |
| JP6617702B2 (ja) | Ｆｔｙ７２０のアザサイクリック拘束アナログ | |
| EP3201178B1 (en) | Arylalkylpiperazines for use as neuroprotective agents | |
| EP3406611A1 (en) | Flavanone derivatives and preparation method and use thereof | |
| JP2021073171A (ja) | （ｒ）−ジミラセタム（１）と（ｓ）−ジミラセタム（２）を非ラセミ比で含む相乗的組成物 | |
| JP5810099B2 (ja) | ５−ｈｔ（２ｂ）受容体でアンタゴニスト活性を有する高選択性５−ｈｔ（２ｃ）受容体アゴニスト | |
| JPWO2005079845A1 (ja) | 片頭痛予防薬 | |
| JP2018527387A (ja) | ２，３，４，５−テトラヒドロピリジン−６−アミン誘導体 | |
| BR112018067663B1 (pt) | Compostos derivados de sulfamato, seus usos e composição farmacêutica | |
| WO2014060366A1 (fr) | Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer | |
| JP6807940B2 (ja) | カルバメート誘導体化合物、その製造方法および用途 | |
| JP2022510362A (ja) | Ｒ－２－（置換スルホニル）－ヘキサヒドロ－ピロロ［１，２－ａ］ピラジン－６（２Ｈ）－オンとＳ－２－（置換スルホニル）－ヘキサヒドロ－ピロロ［１，２－ａ］ピラジン－６（２Ｈ）－オンを非ラセミ比で含む相乗的組成物 | |
| JPH06100509A (ja) | シクロペンテノン化合物及び該化合物を有効成分とする脳機能改善薬 | |
| GB2413322A (en) | Nefopam analogues | |
| KR20170076649A (ko) | 암 치료를 위한 치료제로서의 4-옥소-n-(4-히드록시페닐)레틴아미드 유도체 | |
| HK1257988A1 (zh) | 作为检测点激酶1(chk1)抑制剂的3，5-二取代吡唑及其制备及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |